Islamic Azad University
Mashhad, Khorasan, 91796, Iran
NCT Number: NCT01310361
In some studies once daily amoxicillin therapy might be treatment of choice for Group A β-hemolytic Streptococcus pharyngitis in comparison with three to four times daily treatment with oral penicillin V.
Looking for future studies?
Notify Me6 year–15 year
All sexes
Interventional
Phase 1
Mashhad, Khorasan, 91796, Iran
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Inclusion criteria
Exclusion criteria
It is mentioned underlined in page 10 in research. (Once the throat swab was taken and cultured on plate at the place where the child was examined, hygiene teacher was trained about how to prepare the oral amoxicillin suspension and how to give it to the child. 750 milligrams of amoxicillin was thereafter given to the patient and in order not to infect other school children, the patient was sent home. The following morning, the patient would come to school and was given the second dose of amoxicillin by the hygiene teacher. All oral drugs were bought from a creditable company. In the injection group, 600000 units of penicillin was administered to children who weigh less than 27 kilograms and 1200000 units of penicillin was administered to children who weigh more. After 48 hours, patients were examined again when the result of first culture was ready)
Azad University of Medical Sciences
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02068469
Streptococcal Sore Throat
Norwich, Connecticut, United States
View Trial DetailsNCT06677567
Infections, Otorhinolaryngologic Diseases
Yenimahalle, Ankara, Turkey (Türkiye)
View Trial DetailsNCT07486544
Infections, Otorhinolaryngologic Diseases
Asyut, Egypt
View Trial DetailsNCT06218836
Infections, Otorhinolaryngologic Diseases
New Delhi, National Capital Territory of Delhi, India
View Trial Details